[HTML][HTML] Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: an overview
C Chen, JM Lü, Q Yao - Medical science monitor: international …, 2016 - ncbi.nlm.nih.gov
Uric acid is the final oxidation product of purine metabolism in humans. Xanthine
oxidoreductase (XOR) catalyzes oxidative hydroxylation of hypoxanthine to xanthine to uric …
oxidoreductase (XOR) catalyzes oxidative hydroxylation of hypoxanthine to xanthine to uric …
Therapeutic strategies for the treatment of chronic hyperuricemia: an evidence-based update
This article aims to critically review the evidence on the available therapeutic strategies for
the treatment of hyperuricemia. For this reason, several papers were reviewed. Xanthine …
the treatment of hyperuricemia. For this reason, several papers were reviewed. Xanthine …
[HTML][HTML] Clinical effects of xanthine oxidase inhibitors in hyperuricemic patients
This review aims to critically present the available clinical evidence supporting the treatment
of chronic hyperuricemia with xanthine oxidase inhibitors. For this reason, the studies …
of chronic hyperuricemia with xanthine oxidase inhibitors. For this reason, the studies …
Insights into the relationship between serum uric acid and pulmonary hypertension
Y Zhou, M Chen, J Zheng, X Shui… - Molecular …, 2023 - spandidos-publications.com
Pulmonary hypertension (PH) is a progressive lethal disease, which is characterized by
abnormal vascular remodeling and persistently elevated pulmonary artery pressure …
abnormal vascular remodeling and persistently elevated pulmonary artery pressure …
An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia
M Bove, AFG Cicero, M Veronesi… - Vascular Health and Risk …, 2017 - Taylor & Francis
Several studies suggest that chronic hyperuricemia, the main precursor of gout, is involved
in the pathogenesis of different systemic disorders that affect cardiovascular and renal …
in the pathogenesis of different systemic disorders that affect cardiovascular and renal …
The effect of polymorphism of uric acid transporters on uric acid transport
Z Wang, T Cui, X Ci, F Zhao, Y Sun, Y Li, R Liu… - Journal of …, 2019 - Springer
The abnormal metabolism of uric acid results in many disease such as chronic kidney
disease, hyperuricemia, nephrolithiasis, gout, hypertension, vascular disease and so on …
disease, hyperuricemia, nephrolithiasis, gout, hypertension, vascular disease and so on …
A highly sensitive dual-read assay using nitrogen-doped carbon dots for the quantitation of uric acid in human serum and urine samples
F Li, J Rui, Z Yan, P Qiu, X Tang - Microchimica Acta, 2021 - Springer
A simple dual-read assay for uric acid (UA) was developed based on a combined ratiometric
fluorescent and colorimetric strategy using nitrogen-doped carbon dots (N-CDs). The …
fluorescent and colorimetric strategy using nitrogen-doped carbon dots (N-CDs). The …
Urate-lowering drugs and prevention of cardiovascular disease: the emerging role of xanthine oxidase inhibition
C Borghi, G Desideri - Hypertension, 2016 - Am Heart Assoc
Borghi and Desideri Allopurinol and Cardiovascular Disease 497 the increase in the
endothelium-dependent forearm vasodilatation was enhanced by allopurinol in a dose …
endothelium-dependent forearm vasodilatation was enhanced by allopurinol in a dose …
The effect of xanthine oxidase inhibitors on blood pressure and renal function
M Bove, AFG Cicero, C Borghi - Current Hypertension Reports, 2017 - Springer
Several epidemiological studies have demonstrated the existence of a correlation between
high serum uric acid (SUA) levels, hypertension, and chronic kidney disease (CKD). Xantine …
high serum uric acid (SUA) levels, hypertension, and chronic kidney disease (CKD). Xantine …
Association between serum uric acid levels and coronary artery disease in different age and gender: a cross-sectional study
Y Sun, H Zhang, W Tian, L Shi, L Chen, J Li… - Aging Clinical and …, 2019 - Springer
Background The association between uric acid (UA) and coronary artery disease (CAD) was
controversial. It was still unclear how the UA level changes with age and gender. Aims To …
controversial. It was still unclear how the UA level changes with age and gender. Aims To …